5 things to know about the experimental treatment Charlie Gard might receive
What is "nucleoside bypass therapy," the treatment proposed for Charlie Gard, and how well has it worked in other patients? Here's what to know.
On Monday, Dr. Michio Hirano, a neurologist at Columbia University, will evaluate 11-month old Charlie Gard, the British boy who is on life support because of a rare, lethal disease called mitochondrial depletion syndrome.
Charlie is at the center of a concerning whether his parents can take him abroad to receive experimental treatment. Doctors at the hospital treating Charlie have said that every medical treatment option has already been explored, and
